首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Chinese medical journal pulmonary and critical care medicine

缩写:CHIN MED J PULM CRIT

ISSN:2097-1982

e-ISSN:2772-5588

IF/分区:7.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引111
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yunchao Su,Rudolf Lucas,David J R Fulton et al. Yunchao Su et al.
Endothelial cells (ECs) form a semi-permeable barrier between the interior space of blood vessels and the underlying tissues. Pulmonary endothelial barrier integrity is maintained through coordinated cellular processes involving receptors, ...
Zhen Zheng,Fei Peng,Yong Zhou Zhen Zheng
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes...
Jilei Zhang,Yuru Liu Jilei Zhang
Alveoli serve as the functional units of the lungs, responsible for the critical task of blood-gas exchange. Comprising type I (AT1) and type II (AT2) cells, the alveolar epithelium is continuously subject to external aggressors like pathog...
Phyllis A Dennery,Hongwei Yao Phyllis A Dennery
Cellular senescence is a status of irreversible growth arrest, which can be triggered by the p53/p21cip1 and p16INK4/Rb pathways via intrinsic and external factors. Senescent cells are typically enlarged and flattened, and characterized by ...
Liudi Yao,Zijian Xu,Donna E Davies et al. Liudi Yao et al.
Progressive lung fibrosis is characterised by dysregulated extracellular matrix (ECM) homeostasis. Understanding of disease pathogenesis remains limited and has prevented the development of effective treatments. While an abnormal wound heal...
Sultan Almuntashiri,Abdullah Alhumaid,Yin Zhu et al. Sultan Almuntashiri et al.
Tissue inhibitors of metalloproteases (TIMPs) have caught the attention of many scientists due to their role in various physiological and pathological processes. TIMP-1, 2, 3, and 4 are known members of the TIMPs family. TIMPs exert their b...
Nicholas J Wallbillich,Hua Lu Nicholas J Wallbillich
Lung cancer remains the leading cause of cancer-related deaths worldwide. Despite the recent advances in cancer therapies, the 5-year survival of non-small cell lung cancer (NSCLC) patients hovers around 20%. Inherent and acquired resistanc...
Shi-Yong Sun Shi-Yong Sun
Although the clinical efficacies of third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) such as osimertinib in the treatment of non-small cell lung cancer (NSCLC) with EGFR-activating mutations are pro...
Zhen Zheng,Fei Peng,Yong Zhou Zhen Zheng
The pandemic of coronavirus disease 2019 (COVID‑19), caused by a novel severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has caused an enormous impact on the global healthcare. SARS-CoV-2 infection primarily targets the ...